我国医药制造业国际竞争力研究
|
摘要
一国国际竞争力的强弱直接决定了该国在世界经济中的地位,而各国的国际竞争力,从根本上来说,是由其各产业国际竞争力的强弱所决定的。高新技术产业是目前发展最快的产业之一,医药制造业作为高新技术产业的子行业,也成为各国竞争的焦点。
目前国内外研究医药制造业产业层面和企业层面的论文比较多,但是从竞争力角度来研究该问题的论文比较少,本文正是从医药制造业的竞争力出发,用多种手段研究医药制造业的国际竞争力,具有一定的新颖性。
本文的研究目的是探索如何提高我国医药制造业国际竞争力。文章首先从理论模型角度分析我国医药制造业的竞争力程度,分析了医药制造业竞争实力、竞争潜力和竞争环境,我们得出:我国医药制造业近年来的国际竞争力在不断增强,但是与世界发达国家相比还存在着较大的差距。了解了这些现状以后,本文接着对我国医药制造业及其子行业的竞争力进行了实证研究,采用的方法是主成分分析法,得出我国医药制造业的竞争力不是很高。另外,本文利用因子分析法分析了我国医药制造业竞争力在国际上的位置,以此清楚地找到我国医药制造业国际竞争力同发达国家之间的差距和问题所在,这也是本文最大的创新点。
针对这种情况,本文提出了提高我国医药制造业国际竞争力的措施和建议。
The international competitiveness of a country directly decides its position in the world economy. However, different nations’competitive power is actually determined by their various industries’competitiveness. There is a tremendously growth development in the Hi-Tech industry in the world. Medicine industry is one of the most critical industries among 8 Hi-Techs.
There are also many kinds of researches on Hi-tech and Hi-tech international competitiveness. However, the resrarches on a detailed Hi-tech industry are rare. So the paper tries to analysis on a new angle.
The paper aims to explore ways to enhance the international competitiveness of Chinese medicine industry. It analyzes the international competitiveness condition by theory model. The outcome is the international competitiveness of Chinese medicine industry increases gradually. But there is still big gap compared with the developed countries in the world. Based on the background of the reality and theory, the dissertation discusses the international competitiveness degree, using a famous principle analyze factor model. It shows that Chinese medicine industry’s international competitiveness in very low. And then it analyzed the competitiveness of Chinese medicine industry in the international position by statistic method. In this process, we can easily find the gap and the problems of Chinese medicine industry’s competitiveness, comparing with the developed countries.
Finally, the paper proposes several policies on how to strength the international competitiveness of Chinese medicine industry.
目前国内外研究医药制造业产业层面和企业层面的论文比较多,但是从竞争力角度来研究该问题的论文比较少,本文正是从医药制造业的竞争力出发,用多种手段研究医药制造业的国际竞争力,具有一定的新颖性。
本文的研究目的是探索如何提高我国医药制造业国际竞争力。文章首先从理论模型角度分析我国医药制造业的竞争力程度,分析了医药制造业竞争实力、竞争潜力和竞争环境,我们得出:我国医药制造业近年来的国际竞争力在不断增强,但是与世界发达国家相比还存在着较大的差距。了解了这些现状以后,本文接着对我国医药制造业及其子行业的竞争力进行了实证研究,采用的方法是主成分分析法,得出我国医药制造业的竞争力不是很高。另外,本文利用因子分析法分析了我国医药制造业竞争力在国际上的位置,以此清楚地找到我国医药制造业国际竞争力同发达国家之间的差距和问题所在,这也是本文最大的创新点。
针对这种情况,本文提出了提高我国医药制造业国际竞争力的措施和建议。
The international competitiveness of a country directly decides its position in the world economy. However, different nations’competitive power is actually determined by their various industries’competitiveness. There is a tremendously growth development in the Hi-Tech industry in the world. Medicine industry is one of the most critical industries among 8 Hi-Techs.
There are also many kinds of researches on Hi-tech and Hi-tech international competitiveness. However, the resrarches on a detailed Hi-tech industry are rare. So the paper tries to analysis on a new angle.
The paper aims to explore ways to enhance the international competitiveness of Chinese medicine industry. It analyzes the international competitiveness condition by theory model. The outcome is the international competitiveness of Chinese medicine industry increases gradually. But there is still big gap compared with the developed countries in the world. Based on the background of the reality and theory, the dissertation discusses the international competitiveness degree, using a famous principle analyze factor model. It shows that Chinese medicine industry’s international competitiveness in very low. And then it analyzed the competitiveness of Chinese medicine industry in the international position by statistic method. In this process, we can easily find the gap and the problems of Chinese medicine industry’s competitiveness, comparing with the developed countries.
Finally, the paper proposes several policies on how to strength the international competitiveness of Chinese medicine industry.
引文
[1]陈萦,我国医药制造业的竞争力现状及发展趋势,企业技术开发,2005,12(11):82~84
[2]王延中,经济全球化进程中的我国医药工业:差别与对策,中国卫生经济,2007,16(6):21~24
[3]迈克尔·波特,竞争优势,北京,华夏出版社,1997:87~99
[4] Michael E. Porter, The Competitive Advantage, Creating and Sustaining Superior Performance, The Free Press, New York, 1985:98~154
[5]迈克尔·波特,国家竞争优势,北京,华夏出版社,2002:172~190
[6]余惕君,王伟,国家竞争策略,上海,远东出版社,2002:5
[7]金碚,竞争力经济学,广州,广东经济出版社,2003:28~30
[8] Zvi Griliches and I.Cockburn, Generics and new goods in Pharmaceutical Price Indexes, Harvard-Institute of Economic Research, USA,2001:436~440
[9] Jorg C. Mahlich and Tonmads Roediger-Schluga, The Changing Nature of Pharmaceutical R&D-Opportunities for Asia, ISIE 2001, Pusan, South Korea, 2003:23~36
[10] Mooney K.George, How to Manage for International Competitiveness, International Business Press, New York, 1992:401~406
[11] Daron Acemoglu and Joshua Linn, Market Size in Innovation Theory and Evidence from the pharmaceutical Industry, UCLA Department of Econimics, USA, 2004:127~263
[12] John A.Vernon, the Relationship between Price Regulation and Pharmaceutical Profit Margins, Applied Economics Letters, 2002:255~258
[13] Vankeirsbilck, Export Strategy Building up Technology-Intensive orielltation, 1996 Industry Applications Conference, 1996:2064~2070
[14] Vervaet, Chris, Price Regulation and competition in Pharmaceutical Market, Econometric Society, Japan, 2004:13~17
[15] Abraham, John, Incentives and Pharmaceutical Reimbursement Reforms, The Free Press, New York, 1985, 1:770~775
[16]胡荣华,李罗庚,高新技术产业结构和效益分析,科技与经济,2003,14(2):79~81
[17]狄昂照,吴明录,韩松,李正平,国际竞争力,北京,改革出版社,1992
[18]金碚,中国工业国际竞争力——理论、方法和实证研究,北京,经济管理出版社,1997
[19]金碚,中国企业竞争力报告(2003)——竞争力的性质和源泉,北京,社会科学文献出版社,2003:25~29
[20]穆荣平,中国高技术产业国际竞争力评价指标研究,中国科技论坛,2000,14(3):51~53
[21]陈晓东,汪宏智,对江苏沿江医药制造业发展的调查和分析,产业经济研究,2005,16(3):72~78
[22]胡建国,张秀娟,贵州医药制造业竞争力评价,贵州示范大学学报(自然科学版),2006,24(2):108~112
[23]商月平,袁志远,河北省医药制造业竞争力分析,经济论坛,2005,2:17~18
[24]穆荣平,蔡长塔,中国医药制造业国际竞争力评价,科研管理,2001,22(2):127~135
[25]穆荣平,吴灼亮,中国医药制造业国际竞争力评价(一),世界科学技术——中医药现代化专论,2005,4:1~8
[26]穆荣平,吴灼亮,中国医药制造业国际竞争力评价(二),世界科学技术——中医药现代化专论,2005,5:5~14
[27]胡元佳,王一涛,国内外医药产业政策比较,中国药业,2004,20(5):22~27
[28]白远,罗风基,北京市生物制药产业国际竞争力研究,国际经济合作,2004,5:19~22
[29]陈建南,张京卫,提升广东省医药产业竞争力对策研究,集团经济研究,2005,24(1):151~153
[30] US Information Techbology office, US High-Tech Trade with China and Hong Kong, Export Behavior IMF working Paper, 2001, 8:231~236
[31]郝云宏,王淑贤,中国产业国际竞争力及其界定,武汉大学学报(人文社科版),2000,2:28~34
[32] Siegfried Bender, Kui-Wal Li, Trade and Comparative Advantage of Asia and Latin Americe Manufactured Exports, In APEC Study Center Consortium Conference, Tianjin, China, 2001, 5
[33]赖明勇,万芳,我国高新技术产品出口现状及发展探析,经济界,2004,20(1):21~24
[34] Frank Windmeijer, Douven, Esther Mot, High-Tech products: Import and Export, CPB Netherlands Bureau for Economic Policy Analysis, 2001
[35]中国科技统计年鉴(2007),北京,中国统计出版社,2007
[36]穆荣平,中国高技术产业国际竞争力评价,高技术发展报告,科学出版社,2000,6:11~16
[37]顾海,董艳平,中国医药产业的发展思路探悉,中国药业,2004,20(9):13~16
[38]周叔莲,王伟光,我国高技术行业出口能力影响因素分析,宏观经济研究,2005,14(8):51~54
[39]孟秀红,陈飞虎,加入WTO对我国医药行业的影响及发展策略,中国农村卫生事业导报,2003,2:7~10
[40]裴长洪,王镭,试论国际竞争力的理论概念与分析方法,中国工业经济,2002,4:28~33
[41]张颖丽,高科技产品市场生命周期特征与策略分析,商业研究,2003,8:14~16
[42]王耀中,王梓安,我国高新技术产品出口分布特点及对策思考,求索,2001,14(4):42~47
[43]刘波,甘梅霞,从“国粹”到“国力”有多远?——从国际竞争力钻石体系透视中国中药产业,贵州工业大学学报(社会科学版),2004,6:41~44
[44]孙长森,中国医药产业现状及发展对策,内蒙古科技与经济,2003,4:36~39
[45]蒋海平,颜久兴,朱学慧,医药产业的竞争与发展浅析,天津药学,2001,12:58~63
[46] Bundo Yamada, Internationalization Strategies of Electronics Companies-implications for NIES, OECD Technical Paper No.28.2002-10, 2002
[47]谭双顺,医药制造业国际竞争力实证研究,[硕士学位论文],长沙,湖南大学,2005
[48] Indey Gray, Kenth Skogsrik, The Valuation Relevance of Voluntary Disclosures: A Comparative Analysis of the disclosure Behavior of Major Pharmaceutical Companies in Sweden and the UK, The Wealth of Nations, New York, 2002
[49]郭克莎,加入WTO对我国医药工业的影响与对策,上海医药,2002,7:38~40
[50]鲍克,北京经济技术开发区生物技术及新医药产业发展现状、优势及问题,中国外资,2005,6:26~30
[51]并木信义,瑕瑜互见——日美产业比较,北京,中国财经经济出版社,1990
[52]吴国华,民族医药企业的核心竞争力问题研究,[硕士学位论文],北京,对外经济贸易大学,2004
[53]冒巍巍,范莉,王方华,我国中药产业国际竞争力分析,中药现代化论坛,2003,34(4):289~292
[54]刘祥敏,陈柳钦,天津医药制造业竞争力分析——兼对津京沪医药制造业竞争力进行分析,高技术与产业化,2005,6:27~32
[55]李京文,郭金龙,王宏伟,国际竞争力综合影响因素分析,中国软科学,2001(10):62~66
[56]胡永宏,贺思辉,综合评价方法,北京,科学出版社,2000
[57]郭亚军,综合评价理论与方法,北京,科学出版社,2002
[58]游家兴,如何正确运用因子分析法进行综合评价,统计教育,2003,5:10~11
[59]颜久兴,创新与医药产业,天津药学,2002,2:58~61
[60]邱家学,申国明,国际著名医药公司基本数据分析,中国药业,2004,7:53~57
[61]宋跃征,蔺涛,我国大企业竞争力的测评方法与实证分析,统计研究,2003,7:9~17
[62]张景安,关于提升企业核心竞争力的若干战略思考,企业管理,2004,9:79~84
[63]邢和平,福建工业国际竞争力和主导产业定位,发展研究,2006,8:73~75
[64]陈力,中国医药制造业国际竞争力研究,[硕士学位论文],武汉,武汉理工大学,2006
[65]穆殿平,古佩忠,刘颖,加强我国中药管理、增强国际竞争力,中国药师,2002,5(4):197~198
[66]王丽华,杨志勋,我国中医药产业的国际竞争力研究,国际贸易问题,2003,2:28~32
[67]周寄中,饶涓,中国医药高科技产业及其市场资源配置的态势分析,南开管理评论,2001,1:62~66
[2]王延中,经济全球化进程中的我国医药工业:差别与对策,中国卫生经济,2007,16(6):21~24
[3]迈克尔·波特,竞争优势,北京,华夏出版社,1997:87~99
[4] Michael E. Porter, The Competitive Advantage, Creating and Sustaining Superior Performance, The Free Press, New York, 1985:98~154
[5]迈克尔·波特,国家竞争优势,北京,华夏出版社,2002:172~190
[6]余惕君,王伟,国家竞争策略,上海,远东出版社,2002:5
[7]金碚,竞争力经济学,广州,广东经济出版社,2003:28~30
[8] Zvi Griliches and I.Cockburn, Generics and new goods in Pharmaceutical Price Indexes, Harvard-Institute of Economic Research, USA,2001:436~440
[9] Jorg C. Mahlich and Tonmads Roediger-Schluga, The Changing Nature of Pharmaceutical R&D-Opportunities for Asia, ISIE 2001, Pusan, South Korea, 2003:23~36
[10] Mooney K.George, How to Manage for International Competitiveness, International Business Press, New York, 1992:401~406
[11] Daron Acemoglu and Joshua Linn, Market Size in Innovation Theory and Evidence from the pharmaceutical Industry, UCLA Department of Econimics, USA, 2004:127~263
[12] John A.Vernon, the Relationship between Price Regulation and Pharmaceutical Profit Margins, Applied Economics Letters, 2002:255~258
[13] Vankeirsbilck, Export Strategy Building up Technology-Intensive orielltation, 1996 Industry Applications Conference, 1996:2064~2070
[14] Vervaet, Chris, Price Regulation and competition in Pharmaceutical Market, Econometric Society, Japan, 2004:13~17
[15] Abraham, John, Incentives and Pharmaceutical Reimbursement Reforms, The Free Press, New York, 1985, 1:770~775
[16]胡荣华,李罗庚,高新技术产业结构和效益分析,科技与经济,2003,14(2):79~81
[17]狄昂照,吴明录,韩松,李正平,国际竞争力,北京,改革出版社,1992
[18]金碚,中国工业国际竞争力——理论、方法和实证研究,北京,经济管理出版社,1997
[19]金碚,中国企业竞争力报告(2003)——竞争力的性质和源泉,北京,社会科学文献出版社,2003:25~29
[20]穆荣平,中国高技术产业国际竞争力评价指标研究,中国科技论坛,2000,14(3):51~53
[21]陈晓东,汪宏智,对江苏沿江医药制造业发展的调查和分析,产业经济研究,2005,16(3):72~78
[22]胡建国,张秀娟,贵州医药制造业竞争力评价,贵州示范大学学报(自然科学版),2006,24(2):108~112
[23]商月平,袁志远,河北省医药制造业竞争力分析,经济论坛,2005,2:17~18
[24]穆荣平,蔡长塔,中国医药制造业国际竞争力评价,科研管理,2001,22(2):127~135
[25]穆荣平,吴灼亮,中国医药制造业国际竞争力评价(一),世界科学技术——中医药现代化专论,2005,4:1~8
[26]穆荣平,吴灼亮,中国医药制造业国际竞争力评价(二),世界科学技术——中医药现代化专论,2005,5:5~14
[27]胡元佳,王一涛,国内外医药产业政策比较,中国药业,2004,20(5):22~27
[28]白远,罗风基,北京市生物制药产业国际竞争力研究,国际经济合作,2004,5:19~22
[29]陈建南,张京卫,提升广东省医药产业竞争力对策研究,集团经济研究,2005,24(1):151~153
[30] US Information Techbology office, US High-Tech Trade with China and Hong Kong, Export Behavior IMF working Paper, 2001, 8:231~236
[31]郝云宏,王淑贤,中国产业国际竞争力及其界定,武汉大学学报(人文社科版),2000,2:28~34
[32] Siegfried Bender, Kui-Wal Li, Trade and Comparative Advantage of Asia and Latin Americe Manufactured Exports, In APEC Study Center Consortium Conference, Tianjin, China, 2001, 5
[33]赖明勇,万芳,我国高新技术产品出口现状及发展探析,经济界,2004,20(1):21~24
[34] Frank Windmeijer, Douven, Esther Mot, High-Tech products: Import and Export, CPB Netherlands Bureau for Economic Policy Analysis, 2001
[35]中国科技统计年鉴(2007),北京,中国统计出版社,2007
[36]穆荣平,中国高技术产业国际竞争力评价,高技术发展报告,科学出版社,2000,6:11~16
[37]顾海,董艳平,中国医药产业的发展思路探悉,中国药业,2004,20(9):13~16
[38]周叔莲,王伟光,我国高技术行业出口能力影响因素分析,宏观经济研究,2005,14(8):51~54
[39]孟秀红,陈飞虎,加入WTO对我国医药行业的影响及发展策略,中国农村卫生事业导报,2003,2:7~10
[40]裴长洪,王镭,试论国际竞争力的理论概念与分析方法,中国工业经济,2002,4:28~33
[41]张颖丽,高科技产品市场生命周期特征与策略分析,商业研究,2003,8:14~16
[42]王耀中,王梓安,我国高新技术产品出口分布特点及对策思考,求索,2001,14(4):42~47
[43]刘波,甘梅霞,从“国粹”到“国力”有多远?——从国际竞争力钻石体系透视中国中药产业,贵州工业大学学报(社会科学版),2004,6:41~44
[44]孙长森,中国医药产业现状及发展对策,内蒙古科技与经济,2003,4:36~39
[45]蒋海平,颜久兴,朱学慧,医药产业的竞争与发展浅析,天津药学,2001,12:58~63
[46] Bundo Yamada, Internationalization Strategies of Electronics Companies-implications for NIES, OECD Technical Paper No.28.2002-10, 2002
[47]谭双顺,医药制造业国际竞争力实证研究,[硕士学位论文],长沙,湖南大学,2005
[48] Indey Gray, Kenth Skogsrik, The Valuation Relevance of Voluntary Disclosures: A Comparative Analysis of the disclosure Behavior of Major Pharmaceutical Companies in Sweden and the UK, The Wealth of Nations, New York, 2002
[49]郭克莎,加入WTO对我国医药工业的影响与对策,上海医药,2002,7:38~40
[50]鲍克,北京经济技术开发区生物技术及新医药产业发展现状、优势及问题,中国外资,2005,6:26~30
[51]并木信义,瑕瑜互见——日美产业比较,北京,中国财经经济出版社,1990
[52]吴国华,民族医药企业的核心竞争力问题研究,[硕士学位论文],北京,对外经济贸易大学,2004
[53]冒巍巍,范莉,王方华,我国中药产业国际竞争力分析,中药现代化论坛,2003,34(4):289~292
[54]刘祥敏,陈柳钦,天津医药制造业竞争力分析——兼对津京沪医药制造业竞争力进行分析,高技术与产业化,2005,6:27~32
[55]李京文,郭金龙,王宏伟,国际竞争力综合影响因素分析,中国软科学,2001(10):62~66
[56]胡永宏,贺思辉,综合评价方法,北京,科学出版社,2000
[57]郭亚军,综合评价理论与方法,北京,科学出版社,2002
[58]游家兴,如何正确运用因子分析法进行综合评价,统计教育,2003,5:10~11
[59]颜久兴,创新与医药产业,天津药学,2002,2:58~61
[60]邱家学,申国明,国际著名医药公司基本数据分析,中国药业,2004,7:53~57
[61]宋跃征,蔺涛,我国大企业竞争力的测评方法与实证分析,统计研究,2003,7:9~17
[62]张景安,关于提升企业核心竞争力的若干战略思考,企业管理,2004,9:79~84
[63]邢和平,福建工业国际竞争力和主导产业定位,发展研究,2006,8:73~75
[64]陈力,中国医药制造业国际竞争力研究,[硕士学位论文],武汉,武汉理工大学,2006
[65]穆殿平,古佩忠,刘颖,加强我国中药管理、增强国际竞争力,中国药师,2002,5(4):197~198
[66]王丽华,杨志勋,我国中医药产业的国际竞争力研究,国际贸易问题,2003,2:28~32
[67]周寄中,饶涓,中国医药高科技产业及其市场资源配置的态势分析,南开管理评论,2001,1:62~66